Squarepoint’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,264
Closed -$241K 4758
2023
Q4
$241K Sell
1,264
-67,781
-98% -$12.8M ﹤0.01% 3484
2023
Q3
$13.7M Buy
69,045
+22,637
+49% +$5.35M 0.03% 634
2023
Q2
$13.2M Sell
46,408
-66
-0.1% -$18.3K 0.04% 542
2023
Q1
$10.1M Buy
46,474
+15,510
+50% +$3.02M 0.04% 542
2022
Q4
$6.37M Buy
+30,964
New +$7.83M 0.03% 712
2022
Q2
Sell
-45,449
Closed -$9.42M 3531
2022
Q1
$9.42M Sell
45,449
-16,326
-26% -$2.69M 0.04% 468
2021
Q4
$11M Buy
61,775
+52,128
+540% +$10.3M 0.03% 486
2021
Q3
$1.99M Sell
9,647
-13,351
-58% -$2.62M 0.01% 1205
2021
Q2
$4.36M Buy
+22,998
New +$3.76M 0.02% 786
2021
Q1
Sell
-13,379
Closed -$1.39M 3740
2020
Q4
$1.39M Buy
+13,379
New +$1.16M 0.01% 1139
2020
Q3
Sell
-11,145
Closed -$528K 2925
2020
Q2
$528K Buy
+11,145
New +$459K 0.01% 1292

Other funds holding SWAV

Squarepoint's SWAV Position: Q1 2024 in Review

Squarepoint sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q1 2024, closing a stake of 1,264 shares — an estimated $241K sold.

Squarepoint first reported a position in SWAV in Q2 2020 and held it in 11 quarters. The position peaked at $13.7M in Q3 2023. 488 funds tracked by Wall St. Rank hold SWAV as of Q1 2024.

  • Squarepoint reported no remaining Shockwave Medical, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Squarepoint sold 1,264 Shockwave Medical, Inc. Common Stock shares in Q1 2024, an estimated $241K.
  • Squarepoint first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2020 and held it in 11 quarters.
  • Squarepoint's Shockwave Medical, Inc. Common Stock position peaked at $13.7M in Q3 2023.
  • 488 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q1 2024.

Based on Squarepoint's 13F filing for Q1 2024, filed 15 May 2024.